Publications by authors named "Z Sarkany"

Claim this Profile
R
Reply to "Reconsidering dopaminergic modulation in Alzheimer's disease: A case for levodopa/carbidopa as a disease-modifying agent".
Zsuzsa Sárkány, Joana Damásio, Sandra Macedo-Ribeiro, Pedro M Martins

Alzheimers Dement· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association between the use of levodopa/carbidopa, Alzheimer's disease biomarkers, and cognitive decline among participants in the National Alzheimer's Coordinating Center Uniform Data Set.
Zsuzsa Sárkány, Joana Damásio, Sandra Macedo-Ribeiro, Pedro M Martins

Alzheimers Dement· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges and Advances in the Encapsulation of Bioactive Ingredients Using Whey Proteins.
Manuel Figueiredo, Zsuzsa Sárkány, Fernando Rocha, Pedro M Martins

Foods· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NAGPKin: Nucleation-and-growth parameters from the kinetics of protein phase separation.
Zsuzsa Sárkány, Francisco Figueiredo, Sandra Macedo-Ribeiro, Pedro M Martins

Mol Biol Cell· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug repurposing of dopaminergic drugs to inhibit ataxin-3 aggregation.
Francisco Figueiredo, Zsuzsa Sárkány, Alexandra Silva, Daniela Vilasboas-Campos, Patrícia Maciel

Biomed Pharmacother· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis